Breakthrough Technology Used to Discover Eye Damage from Repeated Intravitreal Injections
Mount Sinai Health System
The 2020 Power List is out and six Wills Eye Hospital faculty Ophthalmologists are named among the most influential figures in the field based on their scope of knowledge and professional achievements. Director of the Wills Eye Ocular Oncology Service Carol L. Shields, MD was listed the #1 most influential ophthalmologist in the world and the only female physician to make the top 10. Leaders were selected based on nominations from readers of the U.K.-based news magazine, The Ophthalmologist that publishes the list. The final top 100 list was released in March 2020.
The American Academy of Ophthalmology shares eye health tips and advice to keep you safe during the COVID-19 pandemic.
Researchers at the National Eye Institute (NEI) have defined a crucial window of time that mice need to key in on visual events.
Americans in many states across the country have been ordered to stay at home or shelter in place, mitigation efforts sorely needed to help stop the spread of COVID-19. But orders that encourage social distancing do not prohibit patients from essential medical visits, such as seeing a retina specialist for treatments that can preserve vision. People with retinal conditions and those experiencing new signs of a retinal disease, such as loss of vision or flashers or floaters, should contact their retina specialist to determine the best course of action.
Nicotinamide can inhibit aggressive cell transformations during wound healing and may be key to the development of therapies to treat fibrotic eye diseases
Teprotumumab, the first FDA-approved medicine for thyroid eye disease, provides significant improvement in eye bulging, regardless of patient gender, age or smoking status, according to a study accepted for presentation at ENDO 2020, the Endocrine Society’s annual meeting, and publication in a special supplemental section of the Journal of the Endocrine Society.
Researchers now report an improved material that could take braille displays to the next level, allowing those who are blind or who have low vision to more easily understand text and images, while lowering cost.
In patients with diabetes, loss of the gland that helps lubricate the eye may be a sign of elevated blood glucose levels, according to research accepted for presentation at ENDO 2020, the Endocrine Society’s annual meeting. The study will be published in the Journal of the Endocrine Society.
New research suggests that eye movements may come before hand movements in actions that require a two-step decision-making process. The study is published ahead of print in the Journal of Neurophysiology (JNP).
In response to the COVID-19 pandemic, Regeneron will temporarily extend physician payment terms for EYLEA® (aflibercept) Injection purchases from authorized distributors to 150 days.
Study published today in the journal of the American Academy of Ophthalmology found no virus in tears of COVID-19 infected patients
Answers from trusted sources regarding macular degeneration care during the COVID-19 outbreak.
The annual Glaucoma 360 Gala at the Grand Hyatt San Francisco honored leaders in glaucoma research innovation and visionary glaucoma advocates helping to raise awareness.
A protein that normally deposits mineralized calcium in tooth enamel may also be responsible for calcium deposits in the back of the eye in people with dry age-related macular degeneration (AMD), according to a study from researchers at the National Eye Institute (NEI).
Vision and eye problems like blurry vision, dry eyes, trouble with depth perception, and problems adjusting to rapid changes in light are much more common in people with Parkinson’s disease than in people without the disorder, according to a study published in the March 11, 2020, online issue of Neurology®, the medical journal of the American Academy of Neurology. The study also found such problems can influence a person’s daily activities.
GRF annual glaucoma research grants will support 12 investigators at prestigious colleges and universities across the United States.
Johns Hopkins Medicine scientists say they have successfully turned back the biological hands of time, coaxing adult human cells in the laboratory to revert to a primitive state, and unlocking their potential to replace and repair damage to blood vessels in the retina caused by diabetes. The findings from this experimental study, they say, advance regenerative medicine techniques aimed at reversing the course of diabetic retinopathy and other blinding eye diseases.
The Shaffer Prize recognizes a researcher whose project best exemplifies the pursuit of innovative ideas in the quest to better understand and cure glaucoma.
Diabetic retinopathy can be diagnosed and graded with the use of a newer scanning technology called ultra-wide field (UWF) imaging, a system that generates high-quality pictures showing most of the retina. Research from the Joslin Diabetes Center’s Beetham Eye Institute has now shown that one technique, UFW fluorescein angiography, detects over three times more microaneurysms than UWF color imaging
Major surgeries such as trabeculectomy and shunts aren’t the only options for treating glaucoma when medicines and laser treatments don’t work.
An artificial intelligence (AI) device that has been fast-tracked for approval by the Food and Drug Administration may help identify newborns at risk for aggressive posterior retinopathy of prematurity (AP-ROP). AP-ROP is the most severe form of ROP and can be difficult to diagnose in time to save vision.
Registration is now open for EyeceleratorTM, a next-generation business conference to further ophthalmic innovation.
Researchers at Case Western Reserve University, funded in part through a Gund-Harrington Scholar grant at University Hospitals in Cleveland, have used used chemically modified lipids—instead of the viruses most commonly used as carriers— to safely deliver gene therapy to fight a rare, but irreversible, genetic eye disorder known as Stargardt disease.
Researchers said the wavelengths at sunrise and sunset have the biggest impact to brain centers that regulate our circadian clock and our mood and alertness.
Wills Eye Hospital is pleased to announce Jose S. Pulido, MD, MS, MBA, MPH, a world-renowned retina and ocular oncology clinician-scientist, has been named the Larry A. Donoso Endowed Chair and Director of the Henry and Corrine Bower Memorial Laboratories for Translational Medicine, the Vickie and Jack Farber Vision Research Center at Wills Eye.
Wills Eye Hospital is pleased to announce John J. Zabinski has been named Chief Development Officer.
During February, the American Academy of Ophthalmology is urging people to protect themselves from vision loss from AMD by getting a baseline eye exam by age 40.
Blind and low-vision Shockers and campus visitors now have a high-tech option for free visual aid on campus offered through an Aira Access agreement with the Wichita State University Office of Disability Services.
Patients with thyroid eye disease who used the minimally invasive insulin-like growth factor I blocking antibody, teprotumumab, experienced improvement in their symptoms, appearance and quality of life, according to a study recently published in The New England Journal of Medicine.
Research to Prevent Blindness (RPB) celebrates the 60th anniversary of its incorporation. Watch the new video about its many sight-saving accomplishments over the past six decades.
New retrospective study indicates that the shift of treatment from systemic chemotherapies to liver-directed therapies provides survival benefits.
The American Academy of Ophthalmology today announced the appointment of seven new members to its 2020 Board of Trustees.
Researchers have identified a novel cellular entry factor for adeno-associated virus vector (AAV) types—the most commonly used viral vectors for in vivo gene therapy.
It would be the first treatment for "dry" age-related macular degeneration and could significantly improve treatment for wet AMD.
A first-of-its-kind conference taking a broad approach to discussing how Optical Coherence Tomography (OCT) can be utilized in valuable ways from the perspective of each section of the eye will take place at Wills Eye Hospital, Saturday, January 25, 2020.
When University of California, Irvine neurobiologist Carey Y.L. Huh, Ph.D., set her sights on discovering more about amblyopia, she brought personal insight to her quest. As a child, Huh was diagnosed with the condition, which is often called “lazy eye.” he and her colleagues have just found that amblyopia originates in an earlier stage of the visual pathway than was previously thought. Their research, which raises the possibility of new treatment approaches, appears in the Journal of Neuroscience.
Wolters Kluwer, Health announced today that it will begin publishing the Journal of Cataract & Refractive Surgery (JCRS) under its Lippincott portfolio as part of a new partnership with the American Society of Cataract and Refractive Surgery (ASCRS) and the European Society of Cataract and Refractive Surgeons (ESCRS). The January 2020 issue of JCRS will be the first to be published by Wolters Kluwer, which will also take over publication of a freely available companion journal, JCRS Online Case Reports.
The Association for Research in Vision and Ophthalmology (ARVO) today announced the launch of a new career development program aimed to provide early-career underrepresented minority (URM) scientists the opportunity to explore novel and innovative ideas through a two-year $100,000 grant.
Researchers say a gene known to be a biomarker of age plays a key role in age-associated functional and anatomical aging in mouse retinas, a finding that has direct relevance to age-related eye diseases.
Overall, Swedish 70-year-olds' eyesight is good, but many could see even better. Six in ten can improve their vision by getting eyeglasses or changing the power of the glasses they already have, according to a new study from the University of Gothenburg.
During Glaucoma Awareness Month in January, the American Academy of Ophthalmology is urging people to be screened, especially if you are at increased risk of glaucoma.
UPMC is the first center in the U.S. to implant a wireless retinal device to treat advanced age-related macular degeneration.
Mount Sinai Doctors Share Tips for Early Detection during Glaucoma Awareness Month
A new survey has uncovered key gaps in American’s knowledge of eye health, and what they don’t know is putting them at risk of vision loss.
An image of your retina may help determine your risk for Alzheimer’s disease even before other symptoms are detectable. Iowa State researchers will use the retinal images, cognitive measurements and economic data to determine if this information can identify risk for Alzheimer’s disease.
An isoelectric point is a common way to characterize viruses. However, it’s not easy. To improve manufacturing for vaccines and gene therapy, a Michigan Tech team uses surface charge to determine the isoelectric point of different viruses. Specifically, they use a single-particle method with atomic force microscopy (AFM).
Anne L Coleman, M.D., Ph.D., has begun her one-year term as the 124th president of the American Academy of Ophthalmology
San Diego Zoo Safari Park and UC San Diego Health experts performed cataract surgery to restore a 3-year-old gorilla’s eyesight.